Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ProSomnus, Inc. - Common Stock (NQ: OSA )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Apr 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about ProSomnus, Inc. - Common Stock

OSA Stock Earnings: ProSomnus Misses EPS, Beats Revenue for Q4 2023
OSA stock results show that ProSomnus missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Earnings Scheduled For March 26, 2024
Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on revenue of $16.68 million. 
Via Benzinga
Roth MKM Maintains Buy Rating for ProSomnus: Here's What You Need To Know
Via Benzinga
Earnings Scheduled For August 3, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million. 
Via Benzinga
Top 4 Health Care Stocks That Are Preparing To Pump This Month
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with the company to exclusively license its novel pre-clinical immunotherapy... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Is Sleep Devices Focused ProSomnus Stock Soaring Today?
ProSomnus Inc (NASDAQ: OSA) announced the publication of a study by the Cureus Journal of Medical Science, highlighting the company's precision oral appliance therapy (OAT) devices for  
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Salesforce Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
Shares of Salesforce, Inc. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time for a breakdown of the biggest pre-market stock movers as we check out all of the hottest news on Thursday morning! 
Via InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
EXCLUSIVE: Sleep Disorder Focused ProSomnus Raises $10M To Fuel Growth, Optimize Operations
ProSomnus Inc (NASDAQ: OSA) has completed a $10 million convertible preferred equity offering led by existing investors Spring Mountain Capital and Cetus Capital. ProSomnus's Executive Chair, CEO, and... 
Via Benzinga
EXCLUSIVE: ProSomnus' Device Therapy Better Than Philip's Device(s) For Sleep-Related Breathing Disorder, Study Shows
ProSomnus Inc (NASDAQ: OSA), a provider of CPAP alternatives for Obstructive Sleep Apnea, announced updated data presented at the ProSleep Conference earlier this month.  The updated data indicate the... 
Via Benzinga
Why Harley-Davidson Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers 
Via Benzinga
Why Avalo Therapeutics Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket
Gainers 
Via Benzinga
EXCLUSIVE: ProSomnus Reports Much Smaller Than Expected Q2 Loss, Revenues Inline With Consensus
Obstructive Sleep Apnea treatment provider ProSomnus Inc (NASDAQ: OSA) reported Q2 revenues of $6.9 million, up 43% Y/Y and a sequential revenue increase of 19%, slightly beating the consensus of $6.4... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 18, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 3, 2023
Via Benzinga
Earnings Scheduled For March 30, 2023
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is estimated to report quarterly loss at $0.12 per share on revenue of $10.80 million. 
Via Benzinga
EXCLUSIVE: ProSomnus Expands In Medical Device Industry With Strong 2022 Results, What You Need To Know
ProSomnus Inc (NASDAQ: OSA), a front-runner in the medical device industry for the treatment of Obstructive Sleep Apnea, issued its unaudited results for the quarter and full year ending Dec. 31,... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
EXCLUSIVE: ProSomnus Concludes Enrollment In Head To Head Study Comparing Its Sleep Device With Philips'
ProSomnus Inc (NASDAQ: OSA) has completed enrollment in the FLOSAT study, a head-to-head, crossover study comparing t 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to know about on Thursday! 
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.